Advertisement
Canadian Journal of Cardiology

The Transcatheter Aortic Valve Implantation (TAVI) Quality Report: A Call to Arms for Improving Quality in Canada

Published:November 22, 2017DOI:https://doi.org/10.1016/j.cjca.2017.11.007

      Abstract

      Transcatheter aortic valve implantation (TAVI) is a disruptive technology that has dramatically changed the way clinicians care for patients with aortic stenosis. In 15 short years, this technology has progressed from first-in-human to the standard of care for high-risk and inoperable patients with aortic stenosis. In 2016 the Canadian Cardiovascular Society published the first ever report of quality of care for TAVI in Canada. This report provided multiple insights into evaluating such care delivered to Canadians and the challenges that lie ahead. In this article, we summarize these challenges and encourage cardiologists to join the call to arms for improving quality of TAVI care in Canada.

      Résumé

      Le remplacement valvulaire aortique par cathéter (TAVI) est une technologie perturbatrice qui a changé considérablement la manière dont les cliniciens soignent les patients atteints d'une sténose aortique. En seulement 15 ans, cette technologie est passée de la première implantation humaine à la norme de soins chez les patients atteints d'une sténose aortique qui sont exposés à un risque élevé et qui sont inopérables. En 2016, la Société canadienne de cardiologie a publié le tout premier rapport sur la qualité des soins liés au TAVI au Canada. Le présent rapport a donné de nombreux aperçus sur l’évaluation de ces soins offerts aux Canadiens et sur les enjeux qui se profilent à l’horizon. Dans cet article, nous faisons la synthèse de ces enjeux et nous incitons les cardiologues à participer à l’amélioration de la qualité des soins liés au TAVI au Canada.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nishimura R.A.
        • Otto C.M.
        • Bonow R.O.
        • et al.
        2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Circulation. 2017; 135: e1159-e1195
        • Mylotte D.
        • Osnabrugge R.L.
        • Windecker S.
        • et al.
        Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization.
        J Am Coll Cardiol. 2013; 62: 210-219
        • Lauck S.
        • Stub D.
        • Webb J.
        Monitoring wait times for transcatheter aortic valve implantation: a need for national benchmarks.
        Can J Cardiol. 2014; 30: 1150-1152
        • Walther T.
        • Hamm C.W.
        • Schuler G.
        • et al.
        Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry.
        J Am Coll Cardiol. 2015; 65: 2173-2180
        • Holmes Jr., D.R.
        • Nishimura R.A.
        • Grover F.L.
        • et al.
        Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry.
        J Am Coll Cardiol. 2015; 66: 2813-2823